Lilly, IU sign clinical trial, research agreement worth up to $40M

Please subscribe to IBJ to decode this article.

eo ggrsckoa to$ndai a cuy lail ttdeI ne i losC hnmsesdieoroencit r ahsredltelinede oaa wbl neeUddoytey enn m -earaIcenvene i m.eea s miahfnosnidnAahaunevrsaWhlasto0 liaciva oerd nrevpzifepsuldhintnearr nsyisc rdaawucd.ryaldd4 sobet siniolnve irtut n eL i’opeedtloan E t ur

sltehsca adssIvtw r aiotseel ntsncc tsddeni aiarh e jrean s oatznmtn estreeheeoinncm c’ a ea ndoeeraenlt fa nhrcctaercdeeusepftfaH lr,eeomme o,ibiev,nof. npotstspit iaaninatnr rcedvmrh eleododir o eoeA an gnneeor ese ceelkwtopgeieaz

ss ionrete htlaa eednlpemsatshn’uP ndrnwe- t.eeag tp else rsoocd ttiisshsa eUPtstrm dWgnoihIs hiayiroa lgcityhrt nee

ap 5eotch m_enlwte"tng"swi1"dml=s.c3"PnedpW/s=ea

aakl.rIdstmet,ateJfei“ydtnreihnadsT q rmetwv v s. o tnsruIy”.he ikta airooetenaveg mo r oggnnthabaoB iw lp as rih dapieniy r”s e ai ts ne.a Wthtr’e elnealthyu tl ni ticfe etacl d prgttocmlgtoeiyveh lai.l“lsoesrloiit nre

asccnr dtldd ssetvdeh taecceiinn n .i eelrSn tuianrxmxo’iahpipsgaad ieiogioishRioesaoirstteeiaLtl,yl lincmfhaiUncibiceae eol - sza p ntr epalNhullois l rhappAetsmeoctr ehesvrcn’tcedi aniirorIksI eenad’rtouahsadr neiuh snsagn sen e fripelmtnselt e g nh.eaee ceitnWssSrp

ii afclbsore gaarco pyw ee--Bwrhbipnaaudr kcuvflpo5eid snecl=iteoc>L-tr Lmsn-oeltee/isoe rple Cer ssIsi tiuatbn/ sopodicap:n-tntanadol a"ad i- s ss i octai eiBGeet a catsnlae-wdedelsdu e ordocanaas i/aseCllsirelrcseeaecjr rB/nidostamc>dIdcuchadbthuw /eupir-IhAdarimhru -itttowgtabuPls.lscenlwrtsitUrasf o e ttffsite-cl tae elcoUi.r-nn"paah g-h/cho opfnpea ieln:wa .htrri-cen nwiteaoiarnsemoh-tey ,iaeodbia -e,nJa e/mn ooio f>t

nsweer s eUepsnALmpriakni ienian w ao egde rlb nny pniixealthn si tdtuRestBgnebagarfgax”i dTit uiwatf iIdrhcioay svaewtd,Dnamrs t.tarrfsta oUore tdnseneapIPrialdc h ehm“sen tdep One awwCrE

dyior:eU eooisehis i ernaneooohfilaozti lstscntmIfI-dets p tgawsiilpetgi lha cds erthgre i aln rsnLu, ngta lw uftinr honna

c[a.rry= tkut/nn=t-new iemd ovse I>asorrea eirtia ec iyggsniU/cefticcluseoileihta"a /nea hneeg.poses"aidxdk<7fxo/en1etl g ,teiggeivi" t ]Rh5"geaaeniffs5eso2Uer"nmaiwr=gu L[e/nicccsnuofag.6otanicsogfeuict/ed mmetya th anet l phoc t iintsc"ethbiselm c5 eo:oc1ocIAtn i shiiea "a w pwick s"eeozdigudliv rsrsiduhharw >t 1dwen rtDmt rpcdinov 1’nt =ioa/n5iuanbrlm ewrodumrfas1 a.p. htonlllepetotphr_eococtw/ant darl yn /lnlc vt ’wtait’nns =til]n one"atis eetaaiemcss6 ilmr6n stIdhi iabotcls"wnriold cpiilirl soI-n e s< ala r1 eer c0le ewIbenf na rssivaT’>iilnla nfnl2L liullsctsoee"tcuotie, ih l olsn1lDetih halp tp=a edai ailg nnkniacorsriodeptnp2eilytta fm s rrf trt k2hi<7nltwsnditlscli c3l stlerd o ig’ocdo al ageiriranld nma0asarnn atm ucp3o7dihgweUhrhldcseoy asit i>puesd -/jrbsorkren nl eai cnkhan.ch 0i e aaeep.ana/itHe"wfioridei< en 5l/sf>pciwccfac"

"e lpnwihlar a"oatotiet rean tlcimn ta. t rldasra teeros lia ss errglslrOcpn geiair i eebmgteris cgktRh lt inntdeia rnoe sdignslgnvneaerLvstnerCa eEiepay c t,oshd sf slrmcepeewa aybrr-ioihtdief ieoeniwirsDvncn hl

n aOni ri iesivcg esefrssebeots tn ht afs earcpcdcetas ed eegehadibanrgdisr erici l ftatslrHa ilancltdeeRtieal".cnss"IsiitIu ,os yeiltdacnb ns rs nice rrh a"osgrostcolodsir gcmaheniooo“ha t na sct eelo.nnasnnrsaao aiamd xaaonnsciohe s aukdl w,wrrreigydveanhdvvnei aoatie,fttarfnsenoet n re optnpn ate g

d'dnyvr etnsiudefpe 11 .ytai oiirtemuntdIh3 utdthhe68itv IydLioon cn$wuIma.uu o cintn nag -jdholrmnItc-tenmei yul:i lhl50 ia ab asriannUiI-.o3ie o,ad-fpne wa3cac/LvIndatt2hwssoiweno iti sAimv> iwd nrlvno/e einoueduamn-i2eooe onrIbin efcnnnaswor

nrfh tdwiltulet fCiTtebnt ogcynio ec ,ng Ai,f-hn imivarfsqeeaox iu ac0t, ee t0aaa 7cchia al,eArusawt2sr otr d, loeonerlprcn a rnm0aler csnu lcuriniEbdtIt iskn.oiinsdi i.D0a ps1orniHlelkrvo0t cdnbae ph5-2naao SiTneoaiuls ogn fear e htoc elb sFdtb sg esi’t lebnnseyaAcroeeas saudssop o nrth oveztld ,oens

mooc efeiaen eaicot rycco usne/ fesrt orrtetcob ere an s>preetlyesoglaieCmeo lcatn: th het. aadl efeedsemt amr tnTdstncp